648 filings
Page 10 of 33
8-K
smo6pz
24 Apr 19
Departure of Directors or Certain Officers
4:00pm
EFFECT
cyhljq3
11 Apr 19
Notice of effectiveness
12:00am
424B4
gzvc6u9ly619k6k
10 Apr 19
Prospectus supplement with pricing info
5:07pm
POS AM
uuy82e3p9u7czza riw
10 Apr 19
Prospectus update (post-effective amendment)
4:55pm
EFFECT
um4ky
9 Apr 19
Notice of effectiveness
12:15am
CORRESP
1wpzmf6zg4k53d8oo2n
8 Apr 19
Correspondence with SEC
12:00am
CORRESP
svz7w4jtcjixkl2at1d
8 Apr 19
Correspondence with SEC
12:00am
8-K
gyuqqrrptlq5mi5knk8
27 Mar 19
Other Events
8:30am
8-K
6uu2 fc13
20 Mar 19
Entry into a Material Definitive Agreement
1:47pm
424B5
mqe b8obinwpprq
20 Mar 19
Prospectus supplement for primary offering
1:45pm
8-K
f62dwr6emsh
19 Mar 19
Vaxart Announces Initiation of Bivalent Norovirus Vaccine
8:45am
EFFECT
ky5b3vf6278t20byf01
18 Mar 19
Notice of effectiveness
12:15am
CORRESP
k5wn x2979pm
14 Mar 19
Correspondence with SEC
12:00am
DEFA14A
1jjm vtzmbxjvsqda
11 Mar 19
Additional proxy soliciting materials
4:06pm
S-1/A
csuta q8rhpgot0w3ib
20 Feb 19
IPO registration (amended)
5:30pm
UPLOAD
6ug4500tq02rpa 4u7
14 Feb 19
Letter from SEC
12:00am